Should You Add RedHill Biopharma Ltd (RDHL) Stock to Your Portfolio Tuesday?

RedHill Biopharma Ltd (RDHL) is near the top in its sector according to InvestorsObserver. RDHL gets an overall rating of 3. That means it scores higher than 3% of stocks. RedHill Biopharma Ltd gets a 77 rank in the Healthcare sector. Healthcare is number 7 out of 11 sectors.

RDHL has an Overall Score of 3. Find out what this means to you and get the rest of the rankings on RDHL!

See Full RDHL Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With RedHill Biopharma Ltd Stock Today?

RedHill Biopharma Ltd (RDHL) stock has fallen -33.61% while the S&P 500 has risen 0.26% as of 9:52 AM on Tuesday, Sep 14. RDHL is lower by -$2.48 from the previous closing price of $7.38 on volume of 2,154,365 shares. Over the past year the S&P 500 has gained 32.41% while RDHL is lower by -48.53%. RDHL lost -$2.30 per share the over the last 12 months. Click Here to get the full Stock Report for RedHill Biopharma Ltd stock.